Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pluri (PLUR)
NASDAQ:PLUR
Holding PLUR?
Track your performance easily
PLUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.07 - $8.49
Previous CloseN/A
Volume1.48K
Average Volume (3M)16.05K
Market Cap
$24.74M
Enterprise Value$43.10M
Total Cash (Recent Filing)$26.11M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Feb 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.09
Shares Outstanding5,558,662
10 Day Avg. Volume19,700
30 Day Avg. Volume16,053
Standard Deviation0.24
R-Squared0.13
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)72.75
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market Cap1.74
Enterprise Value/Revenue72.07
Enterprise Value/Gross Profit133.85
Enterprise Value/Ebitda-2.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pluri News
PremiumCompany Announcements
Pluri Strengthens Leadership Amid Strategic Board Appointment
Ownership Overview
40.31% Insiders
0.06% Mutual Funds
<0.01% Other Institutional Investors
58.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
PLUR FAQ
What was Pluri’s price range in the past 12 months?
Pluri lowest stock price was $4.07 and its highest was $8.48 in the past 12 months.
What is Pluri’s market cap?
Pluri’s market cap is $24.74M.
When is Pluri’s upcoming earnings report date?
Pluri’s upcoming earnings report date is Feb 11, 2025 which is in 11 days.
How were Pluri’s earnings last quarter?
Pluri released its earnings results on Nov 07, 2024. The company reported -$1.077 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.077.
Is Pluri overvalued?
According to Wall Street analysts Pluri’s price is currently Overvalued.
Does Pluri pay dividends?
Pluri does not currently pay dividends.
What is Pluri’s EPS estimate?
Pluri’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pluri have?
Pluri has 5,558,662 shares outstanding.
What happened to Pluri’s price movement after its last earnings report?
Pluri reported an EPS of -$1.077 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.211%.
Which hedge fund is a major shareholder of Pluri?
Currently, no hedge funds are holding shares in PLUR
---
Company Description
Pluri
Pluri is an Israel-based biotechnology company with an advanced cell-based technology platform. It specializes in regenerative medicine and leverages its advanced cell-based technology platform to develop placenta-based cell therapy product candidates for treating muscle injuries and hematologic disorders.
---
Technical Analysis
Bluebird Bio
―
Fate Therapeutics
―
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
---